VAI-SU2C Epigenetics Dream Team
35 results.
Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial
GRAND RAPIDS, Mich. (March 7,…
March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key…
When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…
What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be a more effective…
Last Friday, Stand Up To Cancer (SU2C) hosted its fifth live telecast, which brought together top scientists, actors and musicians in support of cancer research.…
EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any change to their…
Note: This press release was written by Stand Up To Cancer (SU2C). Van Andel Research Institute (VARI) is home to the VARI-SU2C Epigenetics Dream…
GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–